Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective

Bone Reports - Tập 8 - Trang 104-109 - 2018
Estee L. George1, Yi-Ling Lin2, Marnie M. Saunders1
1The University of Akron, Olson Research Center 319, 302 E. Buchtel Ave., Akron, OH 44325, USA
2University of California, Los Angeles School of Dentistry, 10833 Le Conte Ave., Los Angeles, CA 90095, USA

Tài liệu tham khảo

Abu-Id, 2008, “Bis-phossy jaws” – high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J. Craniomaxillofac. Surg., 36, 95, 10.1016/j.jcms.2007.06.008 Advisory Task Force on Bisphosphonate-Related Osteoencrosis of the Jaws, 2007, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws, J. Oral Maxillofac. Surg., 65, 369, 10.1016/j.joms.2006.11.003 Aguirre, 2010, Effects of alendronate on bone healing after tooth extraction in rats, Oral Dis., 16, 674, 10.1111/j.1601-0825.2010.01677.x Allen, 2011, The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing, Odontology, 99, 8, 10.1007/s10266-010-0153-0 Aragon-Ching, 2009, Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents, Cancer Investig., 27, 221, 10.1080/07357900802208608 Bagan, 2013, Bisphosphonates-related osteonecrosis of the jaws: a preliminary study of salivary interleukins, J. Oral Pathol. Med., 42, 405, 10.1111/jop.12021 Bakker, 2009, Tumor necrosis factor α and interleukin-1β modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes, Arthritis Rheum., 60, 3336, 10.1002/art.24920 Bala, 2012, Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization, J. Bone Miner. Res., 27, 825, 10.1002/jbmr.1501 Bivi, 2012, Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation, J. Bone Miner. Res., 27, 374, 10.1002/jbmr.548 Bonewald, 2011, The amazing osteocyte, J. Bone Miner. Res., 26, 229, 10.1002/jbmr.320 Bonewald, 2008, Osteocytes, mechanosensing and Wnt signaling, Bone, 42, 606, 10.1016/j.bone.2007.12.224 Donetti, 2014, Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa, Oral Dis., 20, 466, 10.1111/odi.12154 Drake, 2008, Bisphosphonates: mechanism of action and role in clinical practice, Mayo Clin. Proc., 83, 1032, 10.4065/83.9.1032 Duncan, 1995, Mechanotransduction and the functional response of bone to mechanical strain, Calcif. Tissue Int., 57, 344, 10.1007/BF00302070 Endo, 2017, Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ), Biol. Pharm. Bull., 40, 739, 10.1248/bpb.b16-01020 Epari, 2010, Mechanobiology of bone healing and regeneration: in vivo models, Proc. Inst. Mech. Eng. H, 224, 1543, 10.1243/09544119JEIM808 Feller, 2009, The nature of fibrous dysplasia, Head Face Med, 5, 10.1186/1746-160X-5-22 Fliefel, 2015, Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review, Int. J. Oral Maxillofac. Surg., 44, 568, 10.1016/j.ijom.2015.01.026 Florencio-Silva, 2015, Biology of bone tissue: structure, function, and factors that influence bone cells, Biomed. Res. Int., 2015, 10.1155/2015/421746 Fukuda, 2013, Sema3A regulates bone-mass accrual through sensory innervations, Nature, 497, 490, 10.1038/nature12115 Galvão, 2011, Optimization of the tartrate-resistant acid phosphatase detection by histochemical method, Eur. J. Histochem., 55, 10.4081/ejh.2011.e1 Gong, 2011, Bisphosphonates pathway, Pharmacogenet. Genomics, 21, 50, 10.1097/FPC.0b013e328335729c Gong, 2017, Skeletal site-specific effects of zoledronate on in vivo bone remodeling and in vitro BMSCs osteogenic activity, Sci. Rep., 7 Graves, 2011, Inflammation and uncoupling as mechanisms of periodontal bone loss, J. Dent. Res., 90, 143, 10.1177/0022034510385236 Hansson, 2012, Alveolar ridge resorption after tooth extraction: a consequence of a fundamental principle of bone physiology, J. Dent. Biomech., 3, 10.1177/1758736012456543 Haugh, 2015, The role of integrin αVβ3 in osteocyte mechanotransduction, J. Mech. Behav. Biomed. Mater., 42, 67, 10.1016/j.jmbbm.2014.11.001 He, 2004, LDL receptor-related proteins 5 and 6 in Wnt/b-catenin signaling: arrows point the way, Development, 131, 1663, 10.1242/dev.01117 Hesse, 2014, Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron μCT study, PLoS One, 9, 10.1371/journal.pone.0088481 Heymann, 2010, Bisphosphonates and bone diseases: past, present and future, Curr. Pharm. Des., 16, 2948, 10.2174/138161210793563572 Hikita, 2009, Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats, J. Bone Miner. Res., 27, 663, 10.1007/s00774-009-0090-6 Howie, 2015, A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma, PLoS One, 10, 10.1371/journal.pone.0132520 Huang, 2010, Mechanotransduction in bone repair and regeneration, FASEB J., 24, 3625, 10.1096/fj.10-157370 Ikebe, 2013, Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw, Oral Sci. Int., 10, 1, 10.1016/S1348-8643(12)00045-6 Jacobs, 2015, Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts, Clin Oral Investig, 19, 699, 10.1007/s00784-014-1284-4 Jobke, 2014, Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients, Bone, 59, 37, 10.1016/j.bone.2013.10.024 Kim, 2016, Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw, Clin Oral Investig, 20, 2251, 10.1007/s00784-016-1718-2 Krishnan, 2006, Regulation of bone mass by Wnt signaling, J. Clin. Invest., 116, 1202, 10.1172/JCI28551 Landesberg, 2011, Potential pathophysiological mechanisms in osteonecrosis of the jaw, Ann. N. Y. Acad. Sci., 1218, 62, 10.1111/j.1749-6632.2010.05835.x Lesclous, 2009, Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?, Bone, 45, 843, 10.1016/j.bone.2009.07.011 MacGregor, 1979, An apparatus for measuring the forces of dental extraction, Br. J. Oral Surg., 17, 71, 10.1016/0007-117X(79)90010-6 Manzano-Moreno, 2015, High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis, J. Craniomaxillofac. Surg., 43, 396, 10.1016/j.jcms.2014.12.008 Marie, 2014, Integrin and cadherin signaling in bone: role and potential therapeutic targets, Trends Endocrinol. Metab., 25, 567, 10.1016/j.tem.2014.06.009 Masi, 2007, Calcitonin and calcitonin receptors, Clin. Cases Miner. Bone Metab., 4, 117 Matsumoto, 2013, Regulation of bone resorption and sealing zone formation in osteoclasts occurs through protein kinase B-mediated microtubule stabilization, J. Bone Miner. Res., 28, 1191, 10.1002/jbmr.1844 Matsuo, 2012, Bone cell interactions through Eph/ephrin bone modeling, remodeling and associated diseases, Cell Adhes. Migr., 6, 148, 10.4161/cam.20888 Migliorati, 2013, Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction, J. Am. Dent. Assoc., 144, 406, 10.14219/jada.archive.2013.0134 Negishi-Koga, 2011, Suppression of bone formation by osteoclastic expression of semaphorin 4D, Nat. Med., 17, 1473, 10.1038/nm.2489 Otto, 2012, Bisphosphonate-related osteonecrosis of the jaws – characteristics, risk factors, clinical features, localization and impact on oncological treatment, J. Craniomaxillofac. Surg., 40, 303, 10.1016/j.jcms.2011.05.003 Otto, 2017, Further development of the MRONJ minipig large animal model, J. Craniomaxillofac. Surg., 45, 1503, 10.1016/j.jcms.2017.07.002 Pathak, 2016, Systemic inflammation affects human osteocyte-specific protein and cytokine expression, Calcif. Tissue Int., 98, 596, 10.1007/s00223-016-0116-8 Pazianas, 2014, Bisphosphonates and bone quality, Bonekey Rep., 3 Plotkin, 2013, Beyond gap junctions: Connexin43 and bone cell signaling, Bone, 52, 157, 10.1016/j.bone.2012.09.030 Plotkin, 2008, Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo, J. Bone Miner. Res., 23, 1712, 10.1359/jbmr.080617 Qaisi, 2016, Denosumab related osteonecrosis of the jaw with spontaneous necrosis of the soft palate: report of a life threatening case, Case Rep. Dent., 2016, 5070187 Qing, 2012, Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation, J. Bone Miner. Res., 27, 1018, 10.1002/jbmr.1567 Roelofs, 2010, Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo, J. Bone Miner. Res., 25, 606, 10.1359/jbmr.091009 Ruggiero, 2014, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update, J. Oral Maxillofac. Surg., 72, 1938, 10.1016/j.joms.2014.04.031 Russell, 2011, Bisphosphonates: the first 40 years, Bone, 49, 2, 10.1016/j.bone.2011.04.022 Saia, 2010, Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction, J. Oral Maxillofac. Surg., 68, 797, 10.1016/j.joms.2009.10.026 Sharma, 2013, Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect, Vasc. Cell, 5, 1, 10.1186/2045-824X-5-1 Stenbeck, 2002, Formation and function of the ruffled border in osteoclasts, Semin. Cell Dev. Biol., 13, 285, 10.1016/S1084952102000587 Sutton, 2008, Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice, J. Mol. Endocrinol., 22, 1370, 10.1210/me.2007-0363 Temiyasathit, 2010, The osteocyte primary cilium and its role in bone mechanotransduction, Ann. N. Y. Acad. Sci., 1192, 422, 10.1111/j.1749-6632.2009.05243.x Teti, 1991, Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity, Am. J. Phys., 261, C1, 10.1152/ajpcell.1991.261.1.C1 Tolstunov, 2012, Odontogenic osteomyelitis or bisphosphonate-related osteonecrosis of mandible of patient with autoimmune disease: clinical dilemma, Compend. Contin. Educ. Dent., 33 Turner, 1998, Mechanotransduction and functional response of the skeleton to physical stress: the mechanisms and mechanics of bone adaptation, J. Orthop. Sci., 3, 346, 10.1007/s007760050064 Vidal-Gutiérrez, 2017, Dental extraction following zoledronate, induces osteonecrosis in rat's jaw, Med. Oral Patol. Oral Cir. Bucal., 22, e177 Viviano, 2017, A rare case of osteonecrosis of the jaw related to imatinib, J. Korean Assoc. Oral Maxillofac. Surg., 43, 120, 10.5125/jkaoms.2017.43.2.120 Wang, 2014, Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model, Arthritis Rheumatol., 66, 107, 10.1002/art.38195 Watabe, 2011, Mechanotransduction activates α5β1 integrin and PI3K/Akt signaling pathways in mandibular osteoblasts, Exp. Cell Res., 317, 2642, 10.1016/j.yexcr.2011.07.015 Zafar, 2016, Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts, Clin Oral Investig, 10.1007/s00784-015-1706-y Zara, 2015, Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts, Clin Oral Investig, 19, 601, 10.1007/s00784-014-1280-8 Zhao, 2011, Bidirectional ephrinB2-ephB4 signaling controls bone homeostasis, Cell Metab., 4, 111, 10.1016/j.cmet.2006.05.012